Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-05 Sale | 2022-07-07 4:30 pm | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 12,861 | $3.705 | $47,650 | 530,589 (Direct) | View |
| 2022-06-29 Sale | 2022-07-01 6:55 pm | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 50,139 | $3.6515 | $183,081 | 543,450 (Direct) | View |
| 2021-06-29 Sale | 2021-07-01 6:32 pm | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 79,000 | $22.63 | $1,787,936 | 593,589 (Direct) | View |
| 2019-05-13 Sale | 2019-05-15 4:42 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $36.98 | $369,798 | 49,106 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-04-06 Option Award | 2022-04-08 4:26 pm | N/A 2032-04-06 | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 40,325 | $0 | 40,325 (Direct) | View |
| 2022-02-23 Option Award | 2022-02-25 4:20 pm | N/A 2032-02-23 | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 80,650 | $0 | 80,650 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-20 8:21 pm | N/A 2031-01-19 | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-09-28 Conversion | 2020-09-30 4:39 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 7,373 | $0 | 672,589 (Direct) | View |
| 2020-09-23 Option Award | 2020-09-25 5:14 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 668,745 | $0 | 668,745 (Direct) | View |
Ownership | 2020-09-23 8:30 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 0 | $0 | 3,844 (Direct) | View |
| 2019-06-05 Tax Withholding | 2019-06-07 4:42 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 757 | $37.31 | 17,479 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-15 4:42 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0 | 49,106 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-15 4:42 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 49,106 (Direct) | View |